Fintel reports that on December 17, 2024, Morgan Stanley upgraded their outlook for Quest Diagnostics (NYSE:DGX) from ...

BofA raised the firm’s price target on Quest Diagnostics (DGX) to $182 from $179 and keeps a Buy rating on the shares. The Life Sciences Tools sector underperformed again in FY24 as Pharma and Biotech ...

I and my wife have been using Quest Diagnostics for many years and have classified their services as stellar. Well organized, punctual and patient focused. I have also used the online app for as ...

Looking to get into virtual reality? Meta Quest 3 represents a significant step forward in virtual reality (VR) and a great starting point for everyone. The newly unveiled Meta Quest 3S also ...

A draw in the third Test between Australia and India has spiced up the race to the World Test Championship Final. Australia and India continue to play catch-up with South Africa after the ...